Merck & Co., Inc. acquires Cidara Therapeutics, Inc. for $9.2bn, boosting its pipeline with CD388's strong flu data. Click ...

Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...

TandemAI announced it has secured a $22 million Series A extension to further develop its drug discovery platform, which ...

Arcutis Biotherapeutics announced strong third-quarter 2025 results, reporting revenue of $99.2 million and achieving profitability for the first time, which surpassed analyst expectations. Following ...

While antibody-drug conjugates (ADCs) have emerged as the next-generation platform for the anticancer drug market, the global ...

Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, has for the second consecutive year won two awards in the Regulation Asia Awards for Excellence ...

On 8 November, Guo Guangchang, Chairman of Fosun International, attended the 3rd Pujiang Biopharmaceutical Original Innovation Conference 2025. During the conference, Guo Guangchang stated, "At this ...

Stifel 2025 Healthcare Conference November 11, 2025 10:00 AM ESTCompany ParticipantsOlivier Loeillot - President, CEO ...

The global vaccines market is projected to grow from USD 50.46 billion in 2025 to USD 63.66 billion by 2030, achieving a CAGR ...

A new collection of research papers examines how humans conceptualize numbers and the numeral systems we’ve build around them ...